Abiomed to provide updates on USpella registry, Impella case reviews at CRF annual TCT meeting

Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced its schedule of events at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, scheduled from September 21 - 25, at the Washington Convention Center in Washington, DC.

“Hemodynamic Support for Shock: Choosing Between IABP, Impella and Tandem Heart”

This year, Abiomed is hosting a three-part breakfast series, featuring updates to the USpella registry, Impella case reviews, and real-world applications.

The update to the USpella registry, a U.S. multicenter observational registry of approximately 351 Impella 2.5 patients, will be presented by William O'Neill, M.D., University of Miami, at the Abiomed breakfast session on Thursday, September 23, and also presented later that day by Brijeshwar Maini, M.D., Pinnacle Health and Vascular Institute, during TCT Session III: Optimizing Primary PCI for STEMI in the Cath Lab.

See below for the full schedule of TCT presentations and the Abiomed three-part breakfast series. All breakfast sessions will begin with breakfast from 6:30 - 7:00 a.m. The Impella presentations will begin at 7:00 a.m. for each session.

Abiomed will conduct daily booth demonstrations at Abiomed booth #1403 and hands-on simulations of its heart recovery platforms. The company anticipates live cases utilizing Impella to be broadcast from the participating live case sites in the main arena, coronary theater and structural heart theater in the Washington Convention Center. Abiomed also anticipates panel discussions on the Impella technology throughout the week.

ABIOMED TCT 2010 SCHEDULE OF EVENTS

WEDNESDAY, SEPTEMBER 22

TCT SPEAKING SESSION: 19^th ANNUAL CARDIOVASCULAR NURSE AND TECHNOLOGIST SYMPOSIUM (PART 2) BREAKOUT SESSION I
Room 202A
Washington Convention Center

11:10-11:20 a.m. - "Which Hemodynamic Support Device for Which Patient: IABP and Impella," presented by Brijeshwar Maini, M.D., Pinnacle Health and Vascular Institute

THURSDAY, SEPTEMBER 23

ABIOMED-SPONSORED TCT BREAKFAST SESSION - Part I: "The Case for Hemodynamic Support: Underlying Science and Clinical Evidence"
Room 140A
Washington Convention Center

7:00-8:00 a.m. - Presentations

• USpella Registry Update
  • William O'Neill, M.D., University of Miami
• Science of Hemodynamic Support
  • John Lasala, M.D., PhD, Washington University School of Medicine, Barnes-Jewish Hospital

TCT SPEAKING SESSION: OPTIMIZING PRIMARY PCI FOR STEMI IN THE CATH LAB
Room 147AB
Washington Convention Center

11:17-11:27 a.m. - "Hemodynamic Support for Shock: Choosing Between IABP, Impella and Tandem Heart," presented by Vladimir Dzavik, M.D., University Health Network

11:27-11:37 a.m. - "Experiences with Impella in STEMI: The USPELLA study," presented by Brijeshwar Maini, M.D., Pinnacle Health and Vascular Institute

FRIDAY, SEPTEMBER 24

ABIOMED-SPONSORED TCT BREAKFAST SESSION - Part ll: "Hemodynamic Support Today and in the Future: A Case-Based Review"
Room 140A
Washington Convention Center

7:00-8:00 a.m. - Presentations

• Opening Remarks
  • Srihari Naidu, M.D., Winthrop University Hospital
• Case Reviews and Panel
  • Salman Arain, M.D., Tulane University Heart & Vascular Institute
  • Wissam Gharib, M.D., West Virginia University Cardiology
  • Mark Grise, M.D., John Ochsner Heart and Vascular Institute

• Future Directions of Impella
  • Brijeshwar Maini, M.D., Pinnacle Health and Vascular Institute

SATURDAY, SEPTEMBER 25

ABIOMED-SPONSORED TCT BREAKFAST SESSION - Part III: "Impella Case Review of Award-Winning Fellows' Presentations"
Room 143B
Washington Convention Center

7:00-8:00 a.m. - Presentations

• Opening Remarks and Hospital Impella Experience
  • Theodore Schreiber, M.D., DMC Cardiovascular Institute/Harper University Hospital
• Award Winning Impella Cases
  • Theodore Schreiber, M.D., DMC Cardiovascular Institute/Harper University Hospital
  • Neeraj Jolly, M.D., University of Chicago Medical Center
  • Roxana Mehran, M.D., Mount Sinai Medical Center